QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
Log in
NASDAQ:EPIX

ESSA Pharma Stock Forecast, Price & News

$6.45
-0.48 (-6.93 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.09
Now: $6.45
$6.99
50-Day Range
$6.70
MA: $7.07
$7.79
52-Week Range
$2.85
Now: $6.45
$8.31
Volume119,351 shs
Average Volume62,588 shs
Market Capitalization$193.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Read More
ESSA Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.63 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EPIX
CUSIPN/A
Phone778-331-0962

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.37 per share

Profitability

Net Income$-10,440,000.00

Miscellaneous

Employees15
Market Cap$193.69 million
Next Earnings Date12/17/2020 (Estimated)
OptionableNot Optionable
$6.45
-0.48 (-6.93 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

How has ESSA Pharma's stock price been impacted by Coronavirus?

ESSA Pharma's stock was trading at $4.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EPIX stock has increased by 58.5% and is now trading at $6.45.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of ESSA Pharma?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for ESSA Pharma
.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Thursday, December 17th 2020.
View our earnings forecast for ESSA Pharma
.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc (NASDAQ:EPIX) posted its quarterly earnings results on Thursday, August, 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.05.
View ESSA Pharma's earnings history
.

What price target have analysts set for EPIX?

3 Wall Street analysts have issued 1 year price targets for ESSA Pharma's shares. Their forecasts range from $9.00 to $9.00. On average, they anticipate ESSA Pharma's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 39.5% from the stock's current price.
View analysts' price targets for ESSA Pharma
.

Are investors shorting ESSA Pharma?

ESSA Pharma saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 24,300 shares, a decrease of 20.8% from the August 15th total of 30,700 shares. Based on an average daily volume of 110,900 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the shares of the company are short sold.
View ESSA Pharma's Short Interest
.

Who are some of ESSA Pharma's key competitors?

What other stocks do shareholders of ESSA Pharma own?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 69)
  • Mr. David S. Wood, Chief Financial Officer (Age 62)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 48)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 72)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 58)

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include BVF Inc. IL (9.52%), Omega Fund Management LLC (7.18%), Opaleye Management Inc. (0.84%) and Commonwealth Equity Services LLC (0.12%).

Which major investors are selling ESSA Pharma stock?

EPIX stock was sold by a variety of institutional investors in the last quarter, including BVF Inc. IL, and Omega Fund Management LLC.

Which major investors are buying ESSA Pharma stock?

EPIX stock was acquired by a variety of institutional investors in the last quarter, including Opaleye Management Inc., and Commonwealth Equity Services LLC.

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $6.45.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of $193.69 million. The company earns $-10,440,000.00 in net income (profit) each year or ($1.46) on an earnings per share basis. ESSA Pharma employs 15 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is www.essapharma.com.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.